Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-130,817
Closed -$9.69M 228
2024
Q1
$9.69M Buy
130,817
+3,114
+2% +$217K 0.65% 30
2023
Q4
$8.44M Buy
127,703
+20,462
+19% +$1.28M 0.62% 31
2023
Q3
$6.75M Buy
107,241
+19,174
+22% +$1.19M 0.57% 31
2023
Q2
$4.98M Buy
88,067
+5,852
+7% +$325K 0.42% 40
2023
Q1
$4.76M Buy
82,215
+1,975
+2% +$133K 0.43% 42
2022
Q4
$5.81M Buy
80,240
+3,315
+4% +$237K 0.57% 34
2022
Q3
$4.68M Buy
+76,925
New +$4.91M 0.51% 35

Other funds holding MET

JB Capital's MET Position: Q2 2024 in Review

JB Capital sold out of MetLife (MET) in Q2 2024, closing a stake of 130,817 shares — an estimated $9.69M sold.

JB Capital first reported a position in MET in Q3 2022 and held it in 7 quarters. The position peaked at $9.69M in Q1 2024. 1,298 funds tracked by Wall St. Rank hold MET as of Q2 2024.

  • JB Capital reported no remaining MetLife position as of Q2 2024 after selling out during the quarter.
  • JB Capital sold 130,817 MetLife shares in Q2 2024, an estimated $9.69M.
  • JB Capital first reported a position in MetLife in Q3 2022 and held it in 7 quarters.
  • JB Capital's MetLife position peaked at $9.69M in Q1 2024.
  • 1,298 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on JB Capital's 13F filing for Q2 2024, filed 24 Jul 2024.